Moleculin Biotech, Inc. MBRX
NASDAQ · United States · Health Technology
$0.5038+0.00 (+0.68%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -1.40 | -1.55 | +9.9% | $0 | — | +6.3%$0.57→$0.61 |
| Q1 2026 | 2026-05-14 | -3.54 | -1.66 | -113.3% | — | — | -1.4%$2.14→$2.11 |
| Q3 2025 | 2025-11-13 | -17.00 | -6.58 | -158.4% | — | — | -11.1%$12.20→$10.85 |
| Q2 2025 | 2025-08-12 | -12.25 | -10.08 | -21.5% | — | — | — |
| Q1 2025 | 2025-05-13 | -17.25 | -13.87 | -24.4% | — | — | — |
| Q3 2024 | 2024-11-08 | -71.25 | -61.00 | -16.8% | — | — | — |
| Q2 2024 | 2024-08-13 | -42.50 | -62.75 | +32.3% | — | — | — |
| Q1 2024 | 2024-05-10 | -50.50 | -88.25 | +42.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.